These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 28825656)

  • 21. SANDO syndrome in a cohort of 107 patients with CPEO and mitochondrial DNA deletions.
    Hanisch F; Kornhuber M; Alston CL; Taylor RW; Deschauer M; Zierz S
    J Neurol Neurosurg Psychiatry; 2015 Jun; 86(6):630-4. PubMed ID: 25143630
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A novel mitochondrial tRNAGlu (MTTE) gene mutation causing chronic progressive external ophthalmoplegia at low levels of heteroplasmy in muscle.
    Alston CL; Lowe J; Turnbull DM; Maddison P; Taylor RW
    J Neurol Sci; 2010 Nov; 298(1-2):140-4. PubMed ID: 20810132
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasma FGF-21 and GDF-15 are elevated in different inherited metabolic diseases and are not diagnostic for mitochondrial disorders.
    Tsygankova PG; Itkis YS; Krylova TD; Kurkina MV; Bychkov IO; Ilyushkina AA; Zabnenkova VV; Mikhaylova SV; Pechatnikova NL; Sheremet NL; Zakharova EY
    J Inherit Metab Dis; 2019 Sep; 42(5):918-933. PubMed ID: 31260105
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Elevated serum fibroblast growth factor 21 levels correlate with immune recovery but not mitochondrial dysfunction in HIV infection.
    Payne BA; Price DA; Chinnery PF
    AIDS Res Ther; 2013 Nov; 10(1):27. PubMed ID: 24252301
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Different mitochondrial genetic defects exhibit the same protein signature of metabolism in skeletal muscle of PEO and MELAS patients: A role for oxidative stress.
    Santacatterina F; Torresano L; Núñez-Salgado A; Esparza-Molto PB; Olive M; Gallardo E; García-Arumi E; Blazquez A; González-Quintana A; Martín MA; Cuezva JM
    Free Radic Biol Med; 2018 Oct; 126():235-248. PubMed ID: 30138712
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of novel POLG mutations and multiple mitochondrial DNA deletions with variable clinical phenotypes in a Spanish population.
    González-Vioque E; Blázquez A; Fernández-Moreira D; Bornstein B; Bautista J; Arpa J; Navarro C; Campos Y; Fernández-Moreno MA; Garesse R; Arenas J; Martín MA
    Arch Neurol; 2006 Jan; 63(1):107-11. PubMed ID: 16401742
    [TBL] [Abstract][Full Text] [Related]  

  • 27. FGF-21 as a Potential Biomarker for Mitochondrial Diseases.
    Scholle LM; Lehmann D; Deschauer M; Kraya T; Zierz S
    Curr Med Chem; 2018; 25(18):2070-2081. PubMed ID: 29332568
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Revisiting mitochondrial ocular myopathies: a study from the Italian Network.
    Orsucci D; Angelini C; Bertini E; Carelli V; Comi GP; Federico A; Minetti C; Moggio M; Mongini T; Santorelli FM; Servidei S; Tonin P; Ardissone A; Bello L; Bruno C; Ienco EC; Diodato D; Filosto M; Lamperti C; Moroni I; Musumeci O; Pegoraro E; Primiano G; Ronchi D; Rubegni A; Salvatore S; Sciacco M; Valentino ML; Vercelli L; Toscano A; Zeviani M; Siciliano G; Mancuso M
    J Neurol; 2017 Aug; 264(8):1777-1784. PubMed ID: 28695364
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High molecular weight fibroblast growth factor-2 as a promising prognostic biomarker to predict the occurrence of heart failure in atrial fibrillation patients.
    Sun LY; Qu X; Chen LZ; Chen XX; Zheng GS; Wang ZT; Huang WJ; Zhou H
    Heart Vessels; 2017 Dec; 32(12):1506-1512. PubMed ID: 28689282
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mutations in the SPG7 gene cause chronic progressive external ophthalmoplegia through disordered mitochondrial DNA maintenance.
    Pfeffer G; Gorman GS; Griffin H; Kurzawa-Akanbi M; Blakely EL; Wilson I; Sitarz K; Moore D; Murphy JL; Alston CL; Pyle A; Coxhead J; Payne B; Gorrie GH; Longman C; Hadjivassiliou M; McConville J; Dick D; Imam I; Hilton D; Norwood F; Baker MR; Jaiser SR; Yu-Wai-Man P; Farrell M; McCarthy A; Lynch T; McFarland R; Schaefer AM; Turnbull DM; Horvath R; Taylor RW; Chinnery PF
    Brain; 2014 May; 137(Pt 5):1323-36. PubMed ID: 24727571
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diagnostic screening of mitochondrial DNA mutations in Australian adults 1990-2001.
    Marotta R; Chin J; Quigley A; Katsabanis S; Kapsa R; Byrne E; Collins S
    Intern Med J; 2004; 34(1-2):10-9. PubMed ID: 14748908
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Growth Differentiation Factor 15 Is a Novel Diagnostic Biomarker of Mitochondrial Diseases.
    Ji X; Zhao L; Ji K; Zhao Y; Li W; Zhang R; Hou Y; Lu J; Yan C
    Mol Neurobiol; 2017 Dec; 54(10):8110-8116. PubMed ID: 27889897
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of serum FGF-23, MGP and fetuin-A on calcium-phosphate metabolism in maintenance hemodialysis patients.
    Xiao DM; Wu Q; Fan WF; Ye XW; Niu JY; Gu Y
    Hemodial Int; 2013 Oct; 17(4):483-92. PubMed ID: 23490272
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of fibroblast growth factor (FGF-21) as a biomarker with primary mitochondrial disorders, but not with secondary mitochondrial disorders (Friedreich Ataxia).
    Salehi MH; Kamalidehghan B; Houshmand M; Aryani O; Sadeghizadeh M; Mossalaeie MM
    Mol Biol Rep; 2013 Nov; 40(11):6495-9. PubMed ID: 24078096
    [TBL] [Abstract][Full Text] [Related]  

  • 35. GDF-15, a mitochondrial disease biomarker, is associated with the severity of multiple sclerosis.
    Nohara S; Ishii A; Yamamoto F; Yanagiha K; Moriyama T; Tozaka N; Miyake Z; Yatsuga S; Koga Y; Hosaka T; Terada M; Yamaguchi T; Aizawa S; Mamada N; Tsuji H; Tomidokoro Y; Nakamagoe K; Ishii K; Watanabe M; Tamaoka A
    J Neurol Sci; 2019 Oct; 405():116429. PubMed ID: 31476622
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Progressive External Ophthalmoplegia in Polish Patients-From Clinical Evaluation to Genetic Confirmation.
    Kierdaszuk B; Kaliszewska M; Rusecka J; Kosińska J; Bartnik E; Tońska K; Kamińska AM; Kostera-Pruszczyk A
    Genes (Basel); 2020 Dec; 12(1):. PubMed ID: 33396418
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Skeletal muscle gene expression profiling in mitochondrial disorders.
    Crimi M; Bordoni A; Menozzi G; Riva L; Fortunato F; Galbiati S; Del Bo R; Pozzoli U; Bresolin N; Comi GP
    FASEB J; 2005 May; 19(7):866-8. PubMed ID: 15728662
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plasma levels of fibroblast growth factor-23 and mineral metabolism in diabetic and non-diabetic patients on chronic hemodialysis.
    Kojima F; Uchida K; Ogawa T; Tanaka Y; Nitta K
    Int Urol Nephrol; 2008; 40(4):1067-74. PubMed ID: 18791804
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adult cases of mitochondrial DNA depletion due to TK2 defect: an expanding spectrum.
    Béhin A; Jardel C; Claeys KG; Fagart J; Louha M; Romero NB; Laforêt P; Eymard B; Lombès A
    Neurology; 2012 Feb; 78(9):644-8. PubMed ID: 22345218
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of plasma mitochondrial DNA levels for determining disease severity and prognosis in pediatric sepsis: a case control study.
    Yan HP; Li M; Lu XL; Zhu YM; Ou-Yang WX; Xiao ZH; Qiu J; Li SJ
    BMC Pediatr; 2018 Aug; 18(1):267. PubMed ID: 30092777
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.